9:30 Driving Precision Medicine in Neurology Through Biomarker-Driven Development

  • Exploring biomarker strategies across neurodegenerative therapeutic programs, including Alzheimer’s and rare diseases
  • Insights into the application of targeted antibody therapies in advancing clinical development strategies